Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Milestone Pharmaceuticals Inc. (MIST) is the issuer named in an amended ownership report listing 12,615,010 common shares, or 10.1%, as beneficially owned by each of four reporting persons: Propel Bio Management, LLC, Leen Kawas, Richard Kayne and Propel Bio Partners LLC. The repeated amounts reflect shared attribution rather than four distinct blocks: the report says 9,615,010 shares are held by investment funds and an investment company advised by Propel and Kawas, and 3,000,000 by the Richard and Suzanne Kayne Living Trust, of which Kayne is trustee. The report includes express disclaimers of beneficial ownership and group status. The percentage calculation uses 124,498,693 common shares outstanding as of November 13, 2026.
Key Figures
Reported beneficial ownership:12,615,010 sharesPercentage of class:10.1%Shares held by advised funds:9,615,010 shares+2 more
5 metrics
Reported beneficial ownership12,615,010 sharesReported for each of the four reporting persons
Percentage of class10.1%Reported for each reporting person
Shares held by advised funds9,615,010 sharesDirectly owned by private investment funds and an investment company for which Propel Bio Management, LLC and Leen Kawas provide discretionary advisory services
Shares held by family trust3,000,000 sharesDirectly owned by the Richard and Suzanne Kayne Living Trust
Common shares outstanding124,498,693 sharesAs of November 13, 2026; used for the ownership calculation
"The beneficial ownership of the securities reported herein"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.
Rule 13d-3regulatory
"for purposes of Rule 13d-3"
Rule 13d-3 defines who is treated as the beneficial owner of a company’s shares for U.S. securities disclosure rules — essentially anyone who has the power to vote or direct how shares are voted, or the power to buy or sell them, even if they don’t hold the certificates. For investors this matters because crossing certain ownership thresholds triggers public filing and disclosure obligations and signals potential control or influence, much like having the keys to a car implies you can drive it even if it’s registered to someone else.
Rule 13d-4regulatory
"In accordance with Rule 13d-4"
discretionary advisory servicesfinancial
"provide discretionary advisory services"
sole dispositive powerregulatory
"Sole Dispositive Power 12,615,010.00"
Sole dispositive power is the exclusive legal authority to decide what happens to a security — for example, whether to sell, transfer, or retain shares — without needing anyone else’s permission. Investors care because it signals who truly controls the economic outcome of an investment: like holding the only key to a safe, the holder can realize gains or losses and may trigger regulatory reporting, insider rules, or influence over corporate ownership.
Investment Company Act of 1940regulatory
"registered under the Investment Company Act of 1940"
A U.S. federal law that sets the rulebook for pooled investment vehicles such as mutual funds, exchange-traded funds and similar money managers, requiring them to register with regulators, disclose holdings and fees, limit conflicts of interest, and follow governance standards. It matters to investors because these protections and transparency rules act like a referee and scoreboard, helping people compare funds, trust that managers follow fair practices, and spot hidden costs or risks.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many MIST shares are reported as beneficially owned?
Each of the four reporting persons is listed for 12,615,010 common shares, or 10.1% of the class; the entries reflect shared attribution of the reported holdings, not four separate blocks.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
(Amendment No. 3)
Milestone Pharmaceuticals Inc.
(Name of Issuer)
Common Stock
(Title of Class of Securities)
59935V107
(CUSIP Number)
11/19/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
59935V107
1
Names of Reporting Persons
Propel Bio Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
12,615,010.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
12,615,010.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,615,010.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.1 %
12
Type of Reporting Person (See Instructions)
IA
Comment for Type of Reporting Person: (1) The beneficial ownership of the securities reported herein is described in item 4 of this Schedule 13G. (2) Calculations are based on 124,498,693 common shares outstanding as of November 13, 2026, as disclosed by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 13, 2026.
SCHEDULE 13G
CUSIP Number(s):
59935V107
1
Names of Reporting Persons
Leen Kawas
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
12,615,010.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
12,615,010.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,615,010.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.1 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) The beneficial ownership of the securities reported herein is described in item 4 of this Schedule 13G. (2) Calculations are based on 124,498,693 common shares outstanding as of November 13, 2026, as disclosed by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 13, 2026.
SCHEDULE 13G
CUSIP Number(s):
59935V107
1
Names of Reporting Persons
Richard Kayne
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
12,615,010.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
12,615,010.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,615,010.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.1 %
12
Type of Reporting Person (See Instructions)
IN
Comment for Type of Reporting Person: (1) The beneficial ownership of the securities reported herein is described in item 4 of this Schedule 13G. (2) Calculations are based on 124,498,693 common shares outstanding as of November 13, 2026, as disclosed by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 13, 2026.
SCHEDULE 13G
CUSIP Number(s):
59935V107
1
Names of Reporting Persons
Propel Bio Partners LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
12,615,010.00
6
Shared Voting Power
0.00
7
Sole Dispositive Power
12,615,010.00
8
Shared Dispositive Power
0.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
12,615,010.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
10.1 %
12
Type of Reporting Person (See Instructions)
OO
Comment for Type of Reporting Person: (1) The beneficial ownership of the securities reported herein is described in item 4 of this Schedule 13G. (2) Calculations are based on 124,498,693 common shares outstanding as of November 13, 2026, as disclosed by the Issuer on its Form 10-Q filed with the Securities and Exchange Commission on November 13, 2026.
(i) Propel Bio Management, LLC
(ii) Leen Kawas
(iii) Richard Kayne
(iv) Propel Bio Partners LLC
(b)
Address or principal business office or, if none, residence:
(i) 11620 Wilshire Blvd., Suite 350, Los Angeles, CA 90025
(ii) 11620 Wilshire Blvd., Suite 350, Los Angeles, CA 90025
(iii) 11620 Wilshire Blvd., Suite 350, Los Angeles, CA 90025
(iv) 11620 Wilshire Blvd., Suite 350, Los Angeles, CA 90025
(c)
Citizenship:
(i) Delaware
(ii) United States
(iii) United States
(iv) California
(d)
Title of class of securities:
Common Stock
(e)
CUSIP No.:
59935V107
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
(i) 12,615,010 (1)(2)(3)
(ii)12,615,010 (1)(2)(3)
(iii) 12,615,010 (2)(3)
(iv) 12,615,010 (2)(3)
Footnotes: (1) 9,615,010 Shares are directly owned by private investment funds and an investment company registered under the Investment Company Act of 1940, as amended, for which Propel Bio Management LLC (?Propel?) and Ms. Kawas provide discretionary advisory services. Ms. Kawas is the sole owner of Propel, and possesses voting control and/or the power to direct the disposition of the Shares. Accordingly, for purposes of Rule 13d-3, Propel and Ms. Kawas may be deemed to beneficially own the Shares. In addition, Ms. Kawas and Propel may be considered to form part of a group and therefore, beneficial ownership of all Shares held by group members may be deemed to be attributed to the entire group. In accordance with Rule 13d-4, Propel and Ms. Kawas expressly disclaim beneficial ownership of the Shares and the existence of a group. (2) 3,000,000 Shares are directly owned by the Richard and Suzanne Kayne Living Trust dated 01/14/1999, a family trust (the ?Family Trust?), of which Richard Kayne is the sole trustee. Mr. Kayne, as trustee, possesses voting control and/or power to direct the disposition of the Shares held by the Family Trust. Accordingly, for purposes of Rule 13d-3, Family Trust and Mr. Kayne may be deemed to beneficially own the Shares. In addition, Mr. Kayne and the Family Trust may be considered to form part of a group and therefore, beneficial ownership of all Shares held by group members may be deemed to be attributed to the entire group. In accordance with Rule 13d-4, Mr. Kayne expressly disclaims beneficial ownership of the Shares and the existence of a group. (3) Ms. Kawas, Mr. Kayne, the Family Trust, Propel, and the General Partner may be deemed to form a group and therefore, beneficial ownership of all reported Shares may be attributed to the entire group. In accordance with Rule 13d-4, Ms. Kawas, Mr. Kayne, and the General Partner each expressly disclaim beneficial ownership of the Shares and the existence of a group.
(b)
Percent of class:
(i) 10.1% (1)(2)(3)
(ii) 10.1% (1)(2)(3)
(iii) 10.1% (2)(3)
(iv) 10.1% (2)(3)
Footnotes: (1) 9,615,010 Shares are directly owned by private investment funds and an investment company registered under the Investment Company Act of 1940, as amended, for which Propel Bio Management LLC (?Propel?) and Ms. Kawas provide discretionary advisory services. Ms. Kawas is the sole owner of Propel, and possesses voting control and/or the power to direct the disposition of the Shares. Accordingly, for purposes of Rule 13d-3, Propel and Ms. Kawas may be deemed to beneficially own the Shares. In addition, Ms. Kawas and Propel may be considered to form part of a group and therefore, beneficial ownership of all Shares held by group members may be deemed to be attributed to the entire group. In accordance with Rule 13d-4, Propel and Ms. Kawas expressly disclaim beneficial ownership of the Shares and the existence of a group. (2) 3,000,000 Shares are directly owned by the Richard and Suzanne Kayne Living Trust dated 01/14/1999, a family trust (the ?Family Trust?), of which Richard Kayne is the sole trustee. Mr. Kayne, as trustee, possesses voting control and/or power to direct the disposition of the Shares held by the Family Trust. Accordingly, for purposes of Rule 13d-3, Family Trust and Mr. Kayne may be deemed to beneficially own the Shares. In addition, Mr. Kayne and the Family Trust may be considered to form part of a group and therefore, beneficial ownership of all Shares held by group members may be deemed to be attributed to the entire group. In accordance with Rule 13d-4, Mr. Kayne expressly disclaims beneficial ownership of the Shares and the existence of a group. (3) Ms. Kawas, Mr. Kayne, the Family Trust, Propel, and the General Partner may be deemed to form a group and therefore, beneficial ownership of all reported Shares may be attributed to the entire group. In accordance with Rule 13d-4, Ms. Kawas, Mr. Kayne, and the General Partner each expressly disclaim beneficial ownership of the Shares and the existence of a group.
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
(i) 12,615,010
(ii) 12,615,010
(iii) 12,615,010
(iv) 12,615,010
(ii) Shared power to vote or to direct the vote:
(i) 0
(ii) 0
(iii) 0
(iv) 0
(iii) Sole power to dispose or to direct the disposition of:
(i) 12,615,010
(ii) 12,615,010
(iii) 12,615,010
(iv) 12,615,010
(iv) Shared power to dispose or to direct the disposition of:
(i) 0
(ii) 0
(iii) 0
(iv) 0
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
Reporting persons are holding 10.1% of the shares in the aggregate on behalf of other persons who have the right to receive or the power to direct the receipt of dividends from, or proceeds from the sale of, such securities.
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.